Apheresis Market Shows Huge Demand and Future Scope Including Top Players 2031 | insightSLICE [MarketWatch]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: MarketWatch
Apheresis is a process in which every drop of blood is taken out of the patients' body, to disunite the plasma bearing rogue antibodies. Increasing blood insufficiency and suitabilities of apheresis accumulation over whole blood accommodated by compounding demand for plasma from biopharmaceutical associations are the predominate driving factors for global apheresis market raise. Looking for quantitative data @ https://www.insightslice.com/request-sample/642 Competitive Landscape Some of the major players in the Apheresis market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), and Nikkiso Co., Ltd. (Japan). Players in the Apheresis market are mainly concentrating on new product launches, acquisition, and collaboration to meet the growing demand f
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Haemonetics (HAE) Recently Broke Out Above the 50-Day Moving Average [Yahoo! Finance]Yahoo! Finance
- Haemonetics Corporation (NYSE:HAE) Shares Could Be 35% Below Their Intrinsic Value Estimate [Yahoo! Finance]Yahoo! Finance
- Haemonetics Corporation: Improved Performance, Another Bolt-On Deal [Seeking Alpha]Seeking Alpha
- Haemonetics (HAE) Signs Agreement to Acquire Attune Medical [Yahoo! Finance]Yahoo! Finance
HAE
Earnings
- 2/8/24 - Beat
HAE
Sec Filings
- 3/13/24 - Form 4
- 3/5/24 - Form 8-K
- 2/13/24 - Form SC
- HAE's page on the SEC website